High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan
about
Viral hepatitis and hepatocellular carcinomaRole of occult hepatitis B virus infection in chronic hepatitis CUpdate on occult hepatitis B virus infectionClinical significance of isolated anti-hbc positivity in cases of chronic liver disease in new delhi, IndiaHepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection.Occult hepatitis B virus infection and its clinical implications.Management of hepatocellular carcinoma: advances in diagnosis, treatment and prevention.Four-year follow up of hepatitis C patients vaccinated against hepatitis B virusHepatitis B core IgM antibody (anti-HBcIgM) among hepatitis B surface antigen (HBsAg) negative blood donors in Nigeria.Detection of T lymphocyte subsets and mIL-2R on surface of PBMC in patients with hepatitis B.The Relation between Obesity and Survival after Surgical Resection of Hepatitis C Virus-Related Hepatocellular Carcinoma.Impact of antibody to hepatitis B core antigen on the clinical course of hepatitis C virus carriers in a hyperendemic area in Japan: A community-based cohort study.Multiple infections and cancer: implications in epidemiology.Incidence and risk factors for hepatocellular carcinoma in primary biliary cirrhosis.Occult HBV infection in the oncohematological setting.State of HBV DNA in HBsAg-negative, anti-HCV-positive hepatocellular carcinoma: existence of HBV DNA possibly as nonintegrated form with analysis by Alu-HBV DNA PCR and conventional HBV PCR.High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis.Long-term outcome of Japanese patients with type 1 autoimmune hepatitis.Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
P2860
Q21245597-C418B582-1BAA-4EC9-8342-2BEFD42096B8Q26823538-B6F9BC1A-136D-45F2-8436-C6B954DEB0BEQ28070317-58E41AA3-9832-479D-BD68-95DB2AF24763Q33736413-C2D189CB-2AF2-47E7-A660-6B7B2F7C16D5Q34485074-5836D512-33B8-4BBA-807B-115145CF7C43Q34703532-FE912CD4-142A-47F2-A117-D72163558E3BQ34733981-516642C8-61E5-4119-B0C2-D11B614911E0Q35011088-8824B2C5-00E3-4838-ADD4-66952A940A67Q35617867-15D57B43-8B50-4152-99D1-7A32B5B035B6Q36309223-CE811772-260C-4C51-B85A-C7CC78A0A544Q36848551-979C38E5-FE56-474A-B51F-9D41D25BA503Q37009627-A9BCF095-0366-483C-80E8-DBFC0E0678CDQ38126931-66013ECD-5D83-476E-828A-272CB459D0FDQ38374504-48B25667-655B-46CA-BE0B-F7A1B5196C29Q38807875-DF675661-5320-4FAC-987E-97C80005A22DQ43795086-5F6CD4FA-212D-4C70-A664-96DA46622B29Q43923526-A986E88E-DDE8-412C-8646-C41CB3785F13Q44455344-10240DB9-F1A3-4BE1-AA21-F2A507313F38Q45394122-DEE88C66-74B6-4370-85E6-9C98D1A4E750
P2860
High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
High prevalence of anti-hepati ...... chronic liver disease in Japan
@ast
High prevalence of anti-hepati ...... chronic liver disease in Japan
@en
type
label
High prevalence of anti-hepati ...... chronic liver disease in Japan
@ast
High prevalence of anti-hepati ...... chronic liver disease in Japan
@en
prefLabel
High prevalence of anti-hepati ...... chronic liver disease in Japan
@ast
High prevalence of anti-hepati ...... chronic liver disease in Japan
@en
P2093
P2860
P356
P1433
P1476
High prevalence of anti-hepati ...... chronic liver disease in Japan
@en
P2093
F Moriyasu
H Marusawa
Y Yamamoto
P2860
P304
P356
10.1136/GUT.45.2.284
P407
P50
P577
1999-08-01T00:00:00Z